Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report
Abstract Background To date, this is the only report showing with close and consecutive magnetic resonance images the extremely rapid response of two types of pediatric low-grade gliomas (PLGG) to vemurafenib and its impact on the surgical approach. Cases presentation We report two cases of symptoma...
Saved in:
Main Authors: | Gianluca Piccolo (Author), Antonio Verrico (Author), Giovanni Morana (Author), Gianluca Piatelli (Author), Patrizia De Marco (Author), Valentina Iurilli (Author), Manila Antonelli (Author), Gabriele Gaggero (Author), Antonia Ramaglia (Author), Marco Crocco (Author), Samuele Caruggi (Author), Claudia Milanaccio (Author), Maria Luisa Garrè (Author), Marco Pavanello (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
by: Meijia Yang, et al.
Published: (2017) -
Dabrafenib for treatment of BRAF-mutant melanoma
by: Kainthla R, et al.
Published: (2013) -
Agents to treat BRAF-mutant lung cancer
by: Jean G Bustamante Alvarez, et al.
Published: (2019) -
High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024) -
Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations
by: Erik Hahn, et al.
Published: (2023)